Skip to content
10-K

Annual Report

CALYPTE BIOMEDICAL CORP

0001437749-14-011782

← back to feed
Filed
Jun 24, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Jun 24, 2014 700.17M sh
Operating Cash Flow FY 2012 · Dec 31, 2012 −$682K
Operating Cash Flow FY 2012 · Dec 31, 2011 −$443K
Cash And Equivalents FY 2012 · Dec 31, 2012 $15K
Cash And Equivalents FY 2012 · Dec 31, 2011 $10K
Cash And Equivalents FY 2012 · Dec 31, 2010 $79K
Stockholders Equity FY 2012 · Dec 31, 2012 −$5.26M
Stockholders Equity FY 2012 · Dec 31, 2011 −$5.11M
Stockholders Equity FY 2012 · Dec 31, 2010 −$5.09M
Current Liabilities FY 2012 · Dec 31, 2012 $3.25M
Current Liabilities FY 2012 · Dec 31, 2011 $3.42M
Total Liabilities FY 2012 · Dec 31, 2012 $7.03M
Total Liabilities FY 2012 · Dec 31, 2011 $7.07M
Current Assets FY 2012 · Dec 31, 2012 $199K
Current Assets FY 2012 · Dec 31, 2011 $227K
Total Assets FY 2012 · Dec 31, 2012 $1.77M
Total Assets FY 2012 · Dec 31, 2011 $1.96M
Sga Expense FY 2012 · Dec 31, 2012 $710K
Sga Expense FY 2012 · Dec 31, 2011 $839K
Rd Expense FY 2012 · Dec 31, 2012 $259K
Rd Expense FY 2012 · Dec 31, 2011 $296K
Net Income FY 2012 · Dec 31, 2012 −$1.08M
Net Income FY 2012 · Dec 31, 2011 −$693K
Operating Income FY 2012 · Dec 31, 2012 −$955K
Operating Income FY 2012 · Dec 31, 2011 −$973K
Cost Of Revenue FY 2012 · Dec 31, 2012 $216K
Cost Of Revenue FY 2012 · Dec 31, 2011 $417K